| Literature DB >> 20540807 |
Raymond J Walls1, Gavin McHugh, Donal J O'Gorman, Niall M Moyna, John M O'Byrne.
Abstract
BACKGROUND: Supervised preoperative muscle strengthening programmes (prehabilitation) can improve recovery after total joint arthroplasty but are considered resource intensive. Neuromuscular electrical stimulation (NMES) has been shown to improve quadriceps femoris muscle (QFM) strength and clinical function in subjects with knee osteoarthritis (OA) however it has not been previously investigated as a prehabilitation modality.Entities:
Mesh:
Year: 2010 PMID: 20540807 PMCID: PMC2896350 DOI: 10.1186/1471-2474-11-119
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Baseline demographics
| Group | ||
|---|---|---|
| Male : Female | 3 : 6 | 1 : 4 |
| Age (y) | 64.4 ± 8.0 | 63.2 ± 11.4 |
| Height (cm) | 161.6 ± 13.9 | 155.8 ± 5.3 |
| Weight (kg) | 80.3 ± 13.6 | 79.5 ± 14.6 |
| BMI (kg/m2) | 30.7 ± 3.0 | 32.8 ± 6.3 |
| Maximum Walking time (mins) | 22.8 ± 22.6 | 17.0 ± 10.4 |
Values are means ± SD; BMI: Body Mass Index
Figure 1Quadriceps Femoris Muscle Strength. ap < 0.05 vs. Preoperative; bp < 0.05 vs. + 6 Weeks; Error Bars represent Standard Error
Figure 2Quadriceps Femoris Muscle Cross-sectional Area. ap < 0.05 vs. Preoperative; Error Bars represent Standard Error
Figure 3Objective Functional Capacity. ap < 0.05 vs. Baseline; bp < 0.05 vs. Preoperative; cp < 0.05 vs. + 6 Weeks; *p < 0.05 vs. Control; Error Bars represent Standard Error a) Timed Stair-Climb Test. b) Timed Chair-Rise Test. c) 25 metre Timed Walk Test.
Self-report outcome measures
| Time | ||||
|---|---|---|---|---|
| NMES | 11.7 ± 2.7 | 11.4 ± 3.3 | 7.9 ± 5.9 | 5.4 ± 4.0 a |
| Control | 10.0 ± 5.7 | 11.8 ± 4.0 | 5.4 ± 3.0 | 5.2 ± 4.3 |
| NMES | 36.9 ± 11.3 | 34.7 ± 11.0 | 29.8 ± 16.9 | 19.9 ± 13.9 |
| Control | 37.0 ± 15.7 | 38.4 +/- 14.4 | 24.2 ± 9.9 | 21.6 ± 11.3 |
| NMES | 5.0 ± 2.9 | 5.1 ± 1.8 | 4.6 ± 2.4 | 3.2 ± 2.0 |
| Control | 4.8 ± 1.6 | 5.4 ± 1.3 | 4.6 ± 1.1 | 3.0 ± 1.4 |
| NMES | 41.0 ± 22.1 | 44.4 ± 18.7 | 35.7 ± 17.0 | 57.1 ± 18.0 b |
| Control | 39.0 ± 20.8 | 45.6 ± 17.8 | 39.0 ± 9.4 | 57.0 ± 25.2 |
| NMES | 63.7 ± 18.3 | 62.3 ± 17.5 | 58.6 ± 26.0 | 77.7 ± 14.7 b a |
| Control | 56.4 ± 22.6 | 68.6 ± 23.1 | 58.8 ± 19.5 | 71.0 ± 26.4 |
Values are means ± SD;
WOMAC - Western Ontario McMaster Osteoarthritis Index; SF-36-Short Form 36
ap < 0.05 vs. Preoperative; bp < 0.05 vs. + 6 Weeks
Significant correlations
| Comparison | p value | r value |
|---|---|---|
| Baseline | 0.003 | -0.688 |
| Week 6 | 0.003 | -0.697 |
| Week 12 | 0.005 | -0.662 |
| Baseline | 0.008 | -0.626 |
| Preoperative | 0.020 | -0.552 |
| Week 6 | 0.009 | -0.618 |
| Week 12 | 0.001 | -0.776 |
| Preoperative | 0.032 | -0.508 |
| Baseline | 0.047 | 0.464 |
| Baseline | 0.034 | 0.252 |
| Baseline | 0.009 | -0.623 |
| Week 12 | 0.041 | -0.481 |
| Preoperative | 0.039 | -0.487 |
| Week 12 | 0.026 | -0.528 |
p value - significance level
r value - correlation coefficient
WOMAC - Western Ontario McMaster Osteoarthritis Index
SF-36 - Short Form 36
CSA = Cross-sectional area
TWT = 25-metre timed walk test/TST = Timed stair-climb test/TCT = Timed chair-rise test